A Randomized Phase II Trial to Compare the Safety and Neutralizing Activity of CL184 in Combination With Rabies Vaccine vs. HRIG or Placebo in Combination With Rabies Vaccine in Healthy Adult Subjects

NCT00656097 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

140

Enrollment

INDUSTRY

Sponsor class

Conditions

Rabies

Interventions

BIOLOGICAL: CL184
BIOLOGICAL: HRIG
BIOLOGICAL: Placebo matching CL184

Sponsor

Crucell Holland BV